Fenwick & West LLP advised Atara Biotherapeutics, Inc. on the deal. Atara Biotherapeutics, Inc. (NASDAQ: ATRA), a pioneer in allogeneic T-cell immunotherapy with industry-leading allogeneic cell…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
